RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
White, MV., Silvia, E., Hollis, K., Wooddell, MJ., Goss, D., Odom, D., Bartsch, J., & Hogue, S. (2016). EPIPEN4SCHOOLS® survey combined analysis: Prevalence and triggers of anaphylactic events. Journal of Allergy and Clinical Immunology, 137(2 [Supplement]), Article AB52. https://doi.org/10.1016/j.jaci.2015.12.173
The EPIPEN4SCHOOLS® program (Mylan Specialty L.P., Canonsburg, PA) provides EpiPen® (epinephrine injection) Auto-Injectors to qualifying public and private US schools. Results of a pilot survey described characteristics of anaphylactic events occurring in an initial set of participating schools during the 2013-2014 school year. This survey was subsequently readministered to large US school districts (≥50 schools per district), which were underrepresented in initial survey findings. Here, data from schools in large districts were added to initial findings in a comprehensive combined analysis.
